Customized Prostate Cancer Risk Screening Using Novel Nomograms With MRI

[madman]

Ashley E. Ross, MD, PhD, discusses the novel nomograms he and his team at Northwestern Medicine developed. The nomograms incorporate multiparametric prostate MRI, serum biomarkers and patient clinicodemographic features to help clinicians risk stratify patients with elevated PSA of 2–20 ng/mL who are being considered for biopsy.

The nomograms were internally validated and evaluated in an independent cohort of men. The accuracy of the nomograms was high, with areas under the curves (AUC) of ≥0.885 in the training cohort and ≥0.896 in the independent validation cohort.

 

[madman]

 

[madman]

My nMRIsk Calculator: Optimizing Detection of Clinically Significant Prostate Cancer

Home

Polsky Urologic Cancer Institute offers personalized, innovative urologic cancer care through Northwestern Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

www.feinberg.northwestern.edu

 

[madman]

My nMRIsk Calculator: Optimizing Detection of Clinically Significant Prostate Cancer

 

[madman]

post #6

TRT and the Prostate

Testosterone Treatment and the Risk of Prostate Adverse Events (2022) Jason A. Levy, DO, MS, Arthur L. Burnett, MD, MBA, Adrian S. Dobs, MD, MHS INTRODUCTION Definition Hypogonadism is a clinical syndrome that results from failure of the testis to produce physiologic concentrations of...

www.excelmale.com

 

[madman]

Prostate Snatchers

11:10-1:11:51 Dr. Mark Scholz discusses changes in prostate therapy since the original release of "Invasion of the Prostate Snatchers" 13 years ago. This webinar titled "Invasion of the Prostate Snatchers 13 years later An evening with Dr. Mark Scholz" featured Dr. Scholz discussing prostate...

www.excelmale.com

 

[madman]